Novavax (NVAX)
(Delayed Data from NSDQ)
$4.93 USD
+0.22 (4.67%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.90 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
NVAX 4.93 +0.22(4.67%)
Will NVAX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NVAX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NVAX
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
What's in the Cards for Amgen (AMGN) This Earnings Season?
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Other News for NVAX
Novavax Inc. stock outperforms competitors on strong trading day
Russell 2000 Q1 2024 Earnings Preview: Sharp Downward Revisions Precede Earnings Season
Novavax Inc. stock rises Thursday, still underperforms market
Novavax Inc. stock outperforms competitors on strong trading day
How Is The Market Feeling About Novavax?